NFKB1 and glioblastoma: The long non-coding RNA LBX2-AS1 activates the proinflammatory interleukin-4 receptor by binding to NFKB1, which in turn enhances glioblastoma metastasis and angiogenesis.45 Thus, these core targets can all modulate the risk of glioblastoma through distinct mechanisms.